ABT vs POOL · P/E 25, rev $44.33B vs P/E 18, rev $5.31B
Abbott Laboratories (ABT) versus Pool Corporation (POOL) — a side-by-side from cached financials, not a winner call.
Abbott Laboratories (ABT) is a medical devices company listed on NYSE.
Pool Corporation (POOL) is a industrial distribution company listed on NASDAQ.
Latest reported ABT revenue for 2025-12-31 was $44.33B. Net income was $6.52B. Revenue was up 5.7% from 2024-12-31 to 2025-12-31. ABT currently screens at market cap $154.15B and trailing P/E 24.8.
Latest reported POOL revenue for 2024-12-31 was $5.31B. Net income was $434.3M. Revenue was up 429.5% from 2023-12-31 to 2024-12-31. POOL currently screens at market cap $7.08B and trailing P/E 17.9.
ABT currently screens at market cap $154.15B and trailing P/E 24.8. POOL currently screens at market cap $7.08B and trailing P/E 17.9.
Not investment advice. Open the ABT and POOL stock pages for the full models.
Not investment advice.